| 000 | 01701 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515091338.0 | ||
| 264 | 0 | _c20080409 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a1042-8194 | ||
| 024 | 7 |
_a10.1080/10428190701618284 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLandstrom, Andrew P | |
| 245 | 0 | 0 |
_aPhiladelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: clinical correlates and effect on imatinib mesylate treatment outcome. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cNov 2007 |
||
| 300 |
_a2137-40 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMosaicism _xdrug effects |
| 650 | 0 | 4 | _aPhiladelphia Chromosome |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKnudson, Ryan A | |
| 700 | 1 | _aDewald, Gordon W | |
| 700 | 1 | _aKetterling, Rhett P | |
| 700 | 1 | _aTefferi, Ayalew | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 48 _gno. 11 _gp. 2137-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428190701618284 _zAvailable from publisher's website |
| 999 |
_c17447195 _d17447195 |
||